Document is current
Any future updates will be listed below
-
Authors
Brown, Wendy A.
Fisher, Oliver M.
Johari, Yazmin
Au, Jessica
Stier, Christine
Moore, Rachel
Parmar, Chetan
Dixon, John B.
Salminen, Paulina
- License Information
-
More Information
Article History
Received: 18 August 2025
Revised: 18 August 2025
Accepted: 20 August 2025
First Online: 18 October 2025
Declarations
:
: Not relevant to this type of paper.
: WB reports: Grants from Johnson and Johnson, Medtronic, GORE, Applied Medical, Novo Nordisk, NHMRC, Myerton and the Australian Commonwealth Government. Personal fees from Johnson and Johnson, GORE, Novo Nordisk, Pfizer, Medtronic, Lily and Merck Sharpe and Dohme for lectures and advisory boards. OMF reports: no relevant disclosures YJ reports: no relevant disclosures JA reports: no relevant disclosures CS reports: no relevant disclosures RM reports: no relevant disclosures CP reports: Personal fees from J&J, Medtronics, Boston Scientific for educational lectures JBD reports: Personal fees from Health ED, Novo Nordisk, Lily, Nestle Health Science and Reshape Lifesciences, for lectures, advisory boards and/or consultancies. PS reports: Lecture fees from Novo Nordisk, BD, and Johnson & Johnson. Data safety monitoring committee for GT Metabolic. Research grants Sigrid Jusélius Foundation, Academy of Finland, and European Research Council.
Free to read: This content has been made available to all.
